Ticker LaunchReverse merger · Completed · VANI
Nano Precision Medical, Inc.
Reverse merger with Second Sight Medical Products, Inc. (EYES)
Nano Precision Medical, Inc. merged into Second Sight Medical Products, Inc. (EYES), a Nasdaq-listed developer of the Orion visual prosthesis, in a reverse merger that takes the private company public. The deal was announced on Feb 8, 2022 and closed on Aug 30, 2022. The combined company trades as Vivani Medical, Inc. (VANI) on Nasdaq.
Vivani Medical develops drug and device implants for chronic diseases, led by NPM-119, an exenatide implant for type 2 diabetes using its NanoPortal technology, while exploring options for the Orion visual prosthetic device.
- Status
- Completed
- Private company
- Nano Precision Medical, Inc.
- Public company
- Second Sight Medical Products, Inc. (EYES)
- Public company business before
- Nasdaq-listed developer of the Orion visual prosthesis
- Announced
- Feb 8, 2022
- Closed
- Aug 30, 2022
- Combined company
- Vivani Medical, Inc. (VANI)
- Exchange
- Nasdaq
- Sector
- Medical devices
More on this deal for subscribers
- Ownership split between private and public holders
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
Other completed reverse mergers
- ARS Pharmaceuticals, Inc.into Silverback Therapeutics, Inc. · Nov 8, 2022
- Gix Media Ltd.into Viewbix Inc. · Sep 19, 2022
- Emissions Zero Module, Inc.into New Century Resources Corp · Jul 14, 2022
- Vertex Aerospace (Vertex Holdco)into Vectrus, Inc. · Jul 5, 2022
- SideChannel, Inc.into Cipherloc Corporation · Jul 1, 2022
- Manuka Ltd.into Artemis Therapeutics, Inc. · Jun 30, 2022